rdf:type |
|
lifeskim:mentions |
umls-concept:C0001699,
umls-concept:C0007559,
umls-concept:C0017262,
umls-concept:C0025252,
umls-concept:C0106041,
umls-concept:C0185117,
umls-concept:C0205210,
umls-concept:C0250480,
umls-concept:C0370215,
umls-concept:C0392747,
umls-concept:C0683598,
umls-concept:C1167331,
umls-concept:C2700640,
umls-concept:C2911684
|
pubmed:issue |
2
|
pubmed:dateCreated |
2000-3-23
|
pubmed:abstractText |
We describe Klebsiella pneumoniae 15571, a clinical isolate resistant to ceftazidime MIC = 32 microg/ml) and piperacillin-tazobactam (MICs = 1,024 and 128 microg/ml). K. pneumoniae 15571 expresses a single beta-lactamase with a pI of 7.6. However, when cloned in a high-copy-number vector in Escherichia coli, this bla(SHV-1) gene did not confer resistance to ceftazidime, a spectrum consistent with the nucleotide sequence, which was nearly identical to those of previously described bla(SHV-1) genes. Outer membrane protein (OMP) analysis of K. pneumoniae 15571 revealed a decrease in the quantity of a minor 45-kDa OMP in comparison to that in K. pneumoniae 44NR, a low-level ampicillin-resistant strain that also expresses a chromosomally determined bla(SHV-1). Crude beta-lactamase enzyme extracts from K. pneumoniae 15571 produced roughly 200-fold more beta-lactamase activity than K. pneumoniae 44NR. Northern hybridization analysis revealed that this difference was explainable by quantifiable differences in transcription of the bla(SHV-1) gene in the two strains. Primer extension analysis of bla(SHV-1) mRNA from K. pneumoniae 15571 and 44NR indicated that the transcriptional start sites were identical in the two strains. DNA sequencing of the promoter regions upstream of the of bla(SHV-1) open reading frames in the two K. pneumoniae strains revealed an A-->C change in the second position of the -10 region in K. pneumoniae 44NR compared to that in 15571. Site-directed mutagenesis of the cloned K. pneumoniae 15571 bla(SHV-1), in which the A in the second position of the 15571 -10 region was changed to a C, resulted in a substantial lowering of the MIC of ampicillin. When the levels of beta-lactamase enzyme expression in E. coli were compared, the bla(SHV-1) downstream of the altered -10 region produced 17-fold less beta-lactamase enzyme. These results indicate that elevated levels of ceftazidime resistance can result from a combination of increased enzyme production and minor OMP changes and that levels of chromosomally encoded SHV-1 beta-lactamase production can vary substantially with a single-base-pair change in promoter sequence.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-10217760,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-1952834,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-2033379,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-2073110,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-2197339,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-2221867,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-2982966,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-319999,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-3260490,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-3533626,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-4564689,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-6092432,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-6326054,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-6605714,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-8390809,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-8537652,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-8834877,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-9021210,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-9055993,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-9174192,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-9222043,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-9668979,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10639363-9925535
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Outer Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ceftazidime,
http://linkedlifedata.com/resource/pubmed/chemical/Cephalosporins,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Bacterial,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Penicillanic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Penicillins,
http://linkedlifedata.com/resource/pubmed/chemical/Piperacillin,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Lactamases,
http://linkedlifedata.com/resource/pubmed/chemical/beta-lactamase PIT-2,
http://linkedlifedata.com/resource/pubmed/chemical/tazobactam
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0066-4804
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
362-7
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:10639363-Bacterial Outer Membrane Proteins,
pubmed-meshheading:10639363-Base Sequence,
pubmed-meshheading:10639363-Biological Transport,
pubmed-meshheading:10639363-Ceftazidime,
pubmed-meshheading:10639363-Cephalosporins,
pubmed-meshheading:10639363-Chromosomes,
pubmed-meshheading:10639363-Cloning, Molecular,
pubmed-meshheading:10639363-DNA, Bacterial,
pubmed-meshheading:10639363-Drug Resistance, Microbial,
pubmed-meshheading:10639363-Enzyme Inhibitors,
pubmed-meshheading:10639363-Gene Expression Regulation, Bacterial,
pubmed-meshheading:10639363-Humans,
pubmed-meshheading:10639363-Klebsiella pneumoniae,
pubmed-meshheading:10639363-Microbial Sensitivity Tests,
pubmed-meshheading:10639363-Molecular Sequence Data,
pubmed-meshheading:10639363-Nucleic Acid Hybridization,
pubmed-meshheading:10639363-Penicillanic Acid,
pubmed-meshheading:10639363-Penicillins,
pubmed-meshheading:10639363-Piperacillin,
pubmed-meshheading:10639363-Promoter Regions, Genetic,
pubmed-meshheading:10639363-Sequence Homology, Nucleic Acid,
pubmed-meshheading:10639363-beta-Lactamases
|
pubmed:year |
2000
|
pubmed:articleTitle |
High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.
|
pubmed:affiliation |
Medical Service, Department of Veterans Affairs Medical Center, Cleveland, OH 44106, USA. louis.rice@med.va.gov
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|